Monthly Archives: November 2023

Abstract Prevention of COVID-19 with vaccine requires multiple doses and updated boosters to maintain protection; however currently there are no tests that can measure immunity and guide clinical decisions about timing of booster doses. This study examined the association between the risk of COVID-19 breakthrough infections and receptor binding domain (RBD) antibody levels and receipt […]

This study assessed the presence of SARS-CoV-2 infection rate using Taq man real-time PCR assay and the epidemiological and clinical data of them, in the southwest of Iran during 17 months of post-pandemic period. The mean age of infected patients was 5.71 years that is consistent with Dong et al.’s study [8]. Global data shows mixed […]

Abstract Clinical immunity against Plasmodium falciparum infection develops in residents of malaria endemic regions, manifesting in reduced clinical symptoms during infection and in protection against severe disease but the mechanisms are not fully understood. Here, we compare the cellular and humoral immune response of clinically immune (0-1 episode over 18 months) and susceptible (at least […]

Kawasaki disease, of yet-unknown causes, has seen a sharp decrease since the spread of the novel coronavirus. (Mainichi) TOKYO — Since the coronavirus pandemic began, the number of young children affected by Kawasaki disease in Japan has sharply declined, according to a nonprofit agency that studies the mysterious illness. The disease, discovered by Tomisaku Kawasaki […]

PARIS – Cases of respiratory illnesses have been surging in northern China, particularly among children, sparking speculation online of a new pandemic threat four years after Covid-19 first emerged in the country. However, the Chinese health authorities have said the rising infections are a mix of already known viruses and are linked to the country’s […]